ISSN: 1300 - 6525 E-ISSN: 2149 - 0880
kulak burun boğaz
ve baş boyun cerrahisi dergisi
http://dergi.kbb-bbc.org.tr
Koşulsuz Destek Verenler

Kayıtlı İndeksler








ORIGINAL RESEARCH

The Prognostic Importance of the Systemic Inflammatory Index in Pathologies of the Larynx
Larinks Patolojilerinde Sistemik İnflamatuar İndeksin Prognostik Önemi
Received Date : 30 Oct 2022
Accepted Date : 24 Apr 2023
Available Online : 27 Apr 2023
Doi: 10.24179/kbbbbc.2022-94083 - Makale Dili: EN
KBB ve BBC Dergisi. 2023;31(3):129-34
Copyright © 2020 by Turkey Association of Society of Ear Nose Throat and Head Neck Surgery. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
ABSTRACT
Objective: This study aimed to determine the prognostic importance of the preoperative systemic immune-inflammatory index (SII) in laryngeal lesions and to investigate its predictive importance compared to the neutrophil-lymphocyte ratio (NLR) and plateletlymphocyte ratio (PLR). Material and Methods: Retrospective comparisons were made between the preoperative blood parameters (NLR, PLR, and SII) and clinicopathological features of 133 patients who underwent surgery for a localized laryngeal lesions between 01.03.2010-31.06.2021. Receiver-operating characteristic analysis was used to calculate the cut-off value of the SII. Results: Of the 133 patients with laryngeal lesions, 81 (60.9%) had benign lesions, 20 (15%) had premalignant lesions, and 32 (24.1%) had malignant pathology results. The mean SII value was determined to gradually increase in the order of benign, premalignant and malignant pathology (444.36; 525.69; 738.07, respectively). A statistically significant difference was found between the SII values of the groups classified as benign, premalignant, and malignant according to laryngeal pathologies (p<0.001). A statistically significant moderate-level correlation of approximately 35% was determined between the benign, premalignant, and malignant pathology results and SII, between the pathology results and NLR at 36%, and with PLR at 29%. Conclusion: A significant relationship was observed between the tendency of the disease and malignancy in laryngeal pathologies and the SII. This significant relationship was also determined by NLR and PLR. In this context, the SII was evaluated as an inexpensive, routine screening test that can be used to evaluate the prognosis of patients with laryngeal pathology.
ÖZET
Amaç: Bu çalışmanın amacı, larenks lezyonlarında preoperatif sistemik inflamatuar indeksin [systemic immune-inflammatory index (SII)] prognostik önemini belirlemek ve nötrofil-lenfosit oranı [neutrophil- lymphocyte ratio (NLR)] ve trombosit-lenfosit oranına [platelet- lymphocyte ratio (PLR)] göre prediktif önemini araştırmaktır. Gereç ve Yöntemler: 01.03.2010-31.06.2021 tarihleri arasında, lokalize laringeal lezyon nedeniyle ameliyat edilen 133 hastanın ameliyat öncesi kan parametreleri (NLR, PLR ve SII) ve klinikopatolojik özellikleri retrospektif olarak karşılaştırıldı. Alıcı-işlem karakteristiği analizi SII’nın cut-off değerini hesaplamak için kullanılmıştır. Bulgular: Larenks lezyonu olan 133 hastada yapılan çalışmada 81 (%60,9) hastada benign, 20 (%15) hastada premalign ve 32 (%24,1) hastada malign patoloji sonucu saptandı. Ortalama SII değerinin benign, premalign ve malign patoloji sırasına göre giderek arttığı gözlenmiştir (sırasıyla 444,36; 525,69; 738,07). Laringeal patolojilere göre benign, premalign ve malign olarak sınıflandırılan grupların SII değerleri arasında istatistiksel olarak anlamlı bir fark bulundu (p<0,001). Benign, premalign ve malign patoloji sonuçları ile SII arasında pozitif yönde yaklaşık %35 (orta); NLR arasında yaklaşık %36 (orta) ve PLR ile %29 (orta) oranında istatistiksel olarak anlamlı bir korelasyon vardı. Sonuç: Larenks patolojilerinde hastalığın maligniteye eğilimi ile SII arasında anlamlı bir ilişki olduğu gözlendi. Bu anlamlı ilişki NLR ve PLR arasında da vardı. Bu bağlamda SII, larenks patolojisi olan hastaların prognozunu değerlendirmek için kullanılabilecek ucuz, rutin bir tarama testi olarak değerlendirildi.
KAYNAKLAR
  1. Lin HW, Bhattacharyya N. Staging and survival analysis for nonsquamous cell carcinomas of the larynx. Laryngoscope. 2008;118(6):1003-13. [Crossref]  [PubMed] 
  2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7-30. [Crossref]  [PubMed] 
  3. Steuer CE, El-Deiry M, Parks JR, Higgins KA, Saba NF. An update on larynx cancer. CA Cancer J Clin. 2017;67(1):31-50. [Crossref]  [PubMed] 
  4. American Cancer Society. Cancer Facts and Figures 2019. Atlanta: American Cancer Society, 2019. Available from: [Link] 
  5. Ciolofan MS, Vlăescu AN, Mogoantă CA, Ioniță E, Ioniță I, Căpitănescu AN, et al. Clinical, histological and immunohistochemical evaluation of larynx cancer. Curr Health Sci J. 2017;43(4):367-75. [PubMed]  [PMC] 
  6. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860-7. [Crossref]  [PubMed]  [PMC] 
  7. Topuz MF, Binnetoglu A, Baglam T, Yumusakhuylu AC, Gerin F, Baykan O, et al. Importance of neutrophil/lymphocyte ratio in squamous-cell carcinoma of the larynx. Journal of Otolaryngology Advances. 2016;1(3):15-23. [Crossref] 
  8. Acmaz G, Aksoy H, Unal D, Ozyurt S, Cingillioglu B, Aksoy U, et al. Are neutrophil/lymphocyte and platelet/lymphocyte ratios associated with endometrial precancerous and cancerous lesions in patients with abnormal uterine bleeding? Asian Pac J Cancer Prev. 2014;15(4):1689-92. [Crossref]  [PubMed] 
  9. Hu B, Yang XR, Xu Y, Sun YF, Sun C, Guo W, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20(23):6212-22. [Crossref]  [PubMed] 
  10. Huang J, Zhang Q, Wang R, Ji H, Chen Y, Quan X, et al. Systemic immune-inflammatory index predicts clinical outcomes for elderly patients with acute myocardial infarction receiving percutaneous coronary intervention. Med Sci Monit. 2019;25:9690-9701. [Crossref]  [PubMed]  [PMC] 
  11. Lolli C, Basso U, Derosa L, Scarpi E, Sava T, Santoni M, et al. Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib. Oncotarget. 2016;7(34):54564-71. [Crossref]  [PubMed]  [PMC] 
  12. Hong X, Cui B, Wang M, Yang Z, Wang L, Xu Q. Systemic immune-inflammation index, based on platelet counts and neutrophil-lymphocyte ratio, is useful for predicting prognosis in small cell lung cancer. Tohoku J Exp Med. 2015;236(4):297-304. [Crossref]  [PubMed] 
  13. Hu B, Yang XR, Xu Y, Sun YF, Sun C, Guo W, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20(23):6212-22. [Crossref]  [PubMed] 
  14. Patel SG, Lydiatt WM, Glastonbury CM, et al. Larynx. In: Amin MB, ed. American Joint Committee on Cancer Staging Manual. 8th ed. New York: Springer; 2017. p.149-63. [Crossref] 
  15. Abbas AK, Andrew HL, Shiv P. Immunology of tumors and transplantation. Basic Immunology: Functions and Disorders of the Immune System. 6th ed. Boston, Massachusetts: Elsevier; p.196-217.
  16. Roxburgh CS, McMillan DC. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol. 2010;6(1):149-63. [Crossref]  [PubMed] 
  17. Shen LF, Wang QY, Yu Q. The systemic immune-inflammation index and albumin as prognostic predictors in laryngeal carcinoma. Nutr Cancer. 2021;73(10):1916-23. [Crossref]  [PubMed] 
  18. Demir A, Alan O, Surmeli M. Predictive values of systemic inflammation index in prognosis of patients with laryngeal cancer. EJMO. 2020;4(1):49-53. [Crossref] 
  19. Yılmaz B, Şengül E, Gül A, Alabalık U, Özkurt FE, Akdağ M, et al. Neutrophil-lymphocyte ratio as a prognostic factor in laryngeal carcinoma. Indian J Otolaryngol Head Neck Surg. 2018;70(2):175-9. [Crossref]  [PubMed]  [PMC] 
  20. Wu DQ, Huang XS. [The significance of lymphocyte to monocyte ratio in peripheral blood of patients with benign and malignant laryngeal lesions]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017;31(11):835-8. [PubMed] 
  21. Kum RO, Ozcan M, Baklaci D, Kum NY, Yilmaz YF, Gungor V, et al. Elevated neutrophil-to-lymphocyte ratio in squamous cell carcinoma of larynx compared to benign and precancerous laryngeal lesions. Asian Pac J Cancer Prev. 2014;15(17):7351-5. [Crossref]  [PubMed] 
  22. Chen H, Song S, Zhang L, Dong W, Chen X, Zhou H. Preoperative platelet-lymphocyte ratio predicts recurrence of laryngeal squamous cell carcinoma. Future Oncol. 2020;16(6):209-17. [Crossref]  [PubMed] 
  23. Geng Y, Shao Y, Zhu D, Zheng X, Zhou Q, Zhou W, et al. Systemic immune-inflammation index predicts prognosis of patients with esophageal squamous cell carcinoma: a propensity score-matched analysis. Sci Rep. 2016;6:39482. [Crossref]  [PubMed]  [PMC] 
  24. Xiong J, Kang W, Ma F, Liu H, Ma S, Li Y, et al. Modified systemic inflammation score is an independent predictor of long-term outcome in patients undergoing surgery for adenocarcinoma of the esophagogastric junction. Front Surg. 2021;8:622821. [Crossref]  [PubMed]  [PMC] 
  25. Kanda M, Koike M, Tanaka C, Kobayashi D, Hattori N, Hayashi M, et al. Modified systemic inflammation score is useful for risk stratification after radical resection of squamous cell carcinoma of the esophagus. Ann Surg Oncol. 2019;26(13):4773-81. [Crossref]  [PubMed] 
  26. Huang H, Chen LM, Fang XJ, Guo CC, Lin XP, Hong HM, et al. Prognostic value of the modified systemic inflammation score in patients with extranodal natural killer/T-cell lymphoma. Front Pharmacol. 2020;11:593392. [Crossref]  [PubMed]  [PMC] 
  27. Jiang C, Xiu Y, Yu X, Qiao K, Zhang S, Huang Y. Prognostic value of a modified systemic inflammation score in breast cancer patients who underwent neoadjuvant chemotherapy. BMC Cancer. 2022;22(1):1249. [Crossref]  [PubMed]  [PMC] 
  28. Wang F, Chen L, Wang Z, Xu Q, Huang H, Wang H, et al. Prognostic value of the modified systemic inflammation score in non-small-cell lung cancer with brain metastasis. Cancer Cell Int. 2022;22(1):320. [Crossref]  [PubMed]  [PMC] 
  29. Morkavuk ŞB, Çulcu S, Esen E, Ünal AE. The diagnostic value of modified systemic ınflammation score in predicting post-operative outcomes of cutaneous melanoma patients who underwent ısolated limb perfusion. World J Surg Oncol. 2021;19(1):327. [Crossref]  [PubMed]  [PMC] 
  30. Ataş H, Korukluoğlu B, Çomçali B, Yakşi N, Saylam B, Tez M. Can preoperative modified systemic inflammation score (mSIS) be used to predict malignancy in persistent nondiagnostic thyroid nodules? Turk J Med Sci. 2021;51(2):700-5. [Crossref]  [PubMed]  [PMC] 
  31. Ataş H, Korukluoğlu B, Özdemir BA, Yakşi N, Saylam B, Tez M. Diagnostic value of modified systemic inflammation score for prediction of malignancy in patients with indeterminate thyroid nodules. Am J Surg. 2021;221(1):117-21. [Crossref]  [PubMed] 
  32. Duymaz YK, Tekin AH, Önder S, Şahin Ş, Erkmen B, Savran F, et al. Is modified systemic inflammation score a predictor of malignancy in indeterminate thyroid nodules? Journal of Ear Nose Throat and Head Neck Surgery. [Crossref]